Director/PDMR Shareholding

RNS Number : 1938H

GlaxoSmithKline PLC

05 June 2017

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr L Debruyne
b)	Position/status	President, Global Vaccines
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The sale of 20,000 Ordinary Shares on 2 June 2017 at a price of £17.0177
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£17.0177	20,000
d)	Aggregated information	n/a (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2017-06-02
f)	Place of the transaction	London Stock Exchange (XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr I W Whyte
b)	Position/status	PCA of Mrs V A Whyte (SVP & Company Secretary)
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of 1,310 Ordinary Shares to spouse for nil consideration.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£0.00	1,310
d)	Aggregated information	n/a (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2017-06-02
f)	Place of the transaction	n/a

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mrs V A Whyte
b)	Position/status	SVP & Company Secretary
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The receipt of 1,310 Ordinary Shares from spouse for nil consideration.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£0.00	1,310
d)	Aggregated information	n/a (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2017-06-02
f)	Place of the transaction	n/a

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mrs V A Whyte
b)	Position/status	SVP & Company Secretary
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The sale of 9,215 Ordinary Shares on 2 June 2017 at a price of £17.07.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£17.07	9,215
d)	Aggregated information	n/a (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2017-06-02
f)	Place of the transaction	London Stock Exchange (XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr I W Whyte
b)	Position/status	PCA of Mrs V A Whyte (SVP & Company Secretary)
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The sale of 4,690 Ordinary Shares 2 June 2017 at a price of £17.07.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£17.07	4,690
d)	Aggregated information	n/a (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2017-06-02
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHQELFBDQFLBBF